Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Pogledi
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Prikaži više
Komentari na Facebooku
Nema komentara